Copyright © 2019 by  S M Discovery Group. All rights reserved.

SMDG in the News and media coverage

We are still adding more news coverage about SMDG, please check back again soon

The Medicine Maker

Beyond the Barrier

November 12, 2019

The blood-brain barrier (BBB) represents a formidable foe for drug delivery scientists, who have experimented with numerous angles of attack. “Over the years, complex design (with poor pharmaceutical attributes), poor target recognition, low frequency of crossing the BBB, and poor ability to subsequently target parenchymal cells (for example, neurons and microglia cells) are among some of the major challenges for achieving drug delivery to the brain,” says Moein Moghimi, Professor of Pharmaceutics and Nanomedicine at Newcastle University. 

Market Business Insider

Unlocking the Blood-Brain-Barrier: A new simple and innovative way of delivering therapeutics to the brain

October 15, 2019

Professor Moein Moghimi, who led the research team, said, "Crossing the blood-brain-barrier has been a major impediment to effectively addressing central nervous system diseases, including brain tumors, and many neurological diseases like Parkinson's, Alzheimer's and Huntington's. This breakthrough, based on more than 10 years of research, has significant implications for crossing the blood-brain-barrier and other biological barriers that have created challenges for drug delivery."

Finanzen.net  Germany

Unlocking the Blood-Brain-Barrier: A new simple and innovative way of delivering therapeutics to brain

October 15, 2019

Professor Moghimi and his team engineered small particles using a peptide that can behave like a carrier (like viruses) to the brain and can be packed with drugs for intravenous injection. This allows for minimally invasive and combination drug delivery to the brain.

European Pharmaceutical Review

New breakthrough can effectively deliver medications into the brain

October 16, 2019

Scientists have found a way to effectively transport medication into the brain which could lead to improved treatments for neurological and neurodegenerative diseases.

Bio New Jersey

Unlocking the Blood-Brain-Barrier: A new simple and innovative way of delivering therapeutics to brain

October 15, 2019

Scientists have traditionally faced the problem that blood capillaries in the brain are not permeable to many drugs. In fact, the majority of drugs are excluded from the brain by a protective barrier, called the blood-brain-barrier (BBB), and current treatment options are risky and challenging.

International Business Times

Unlocking the Blood-Brain-Barrier: A new simple and innovative way of delivering therapeutics to brain

October 15, 2019

Professor Moein Moghimi, who led the research team, said, "Crossing the blood-brain-barrier has been a major impediment to effectively addressing central nervous system diseases, including brain tumors, and many neurological diseases like Parkinson's, Alzheimer's and Huntington's. This breakthrough, based on more than 10 years of research, has significant implications for crossing the blood-brain-barrier and other biological barriers that have created challenges for drug delivery."

Denver Cityroom

New Unlocking the Blood-Brain-Barrier: A new simple and innovative way of delivering therapeutics to brain

October 15, 2019

In a groundbreaking study published October 11 in Nature Communications, an international team of scientists from Newcastle University and Denver-based S M Discovery Group (SMDG) have designed a carrier system that delivers medicines to the brain through intravenous injection.

Dow Theory Letters - Financial Markets

Unlocking the Blood-Brain-Barrier

October 15, 2019

Professor Moein Moghimi, who led the research team, said, "Crossing the blood-brain-barrier has been a major impediment to effectively addressing central nervous system diseases, including brain tumors, and many neurological diseases like Parkinson's, Alzheimer's and Huntington's. This breakthrough, based on more than 10 years of research, has significant implications for crossing the blood-brain-barrier and other biological barriers that have created challenges for drug delivery."